A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

NCT02518113 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

T-cell Acute Lymphoblastic Leukemia
T-cell Lymphoblastic Lymphoma

Interventions

DRUG: LY3039478
DRUG: Dexamethasone
DRUG: Placebo

Sponsor

Eli Lilly and Company